Home Determination of age- and sex-specific 99th percentiles for high-sensitive troponin T from patients: an analytical imprecision- and partitioning-based approach
Article
Licensed
Unlicensed Requires Authentication

Determination of age- and sex-specific 99th percentiles for high-sensitive troponin T from patients: an analytical imprecision- and partitioning-based approach

  • Denis Monneret EMAIL logo , Martin Gellerstedt and Dominique Bonnefont-Rousselot
Published/Copyright: November 25, 2017

Abstract

Background:

Detection of acute myocardial infarction (AMI) is mainly based on a rise of cardiac troponin with at least one value above the 99th percentile upper reference limit (99th URL). However, circulating high-sensitive cardiac troponin T (hs-cTnT) concentrations depend on age, sex and renal function. Using an analytical imprecision-based approach, we aimed to determine age- and sex-specific hs-cTnT 99th URLs for patients without chronic kidney disease (CKD).

Methods:

A 3.8-year retrospective analysis of a hospital laboratory database allowed the selection of adult patients with concomitant plasma hs-cTnT (<300 ng/L) and creatinine concentrations, both assayed twice within 72 h with at least 3 h between measurements. Absence of AMI was assumed when the variation between serial hs-cTnT values was below the adjusted-analytical change limit calculated according to the inverse polynomial regression of analytical imprecision. Specific URLs were determined using Clinical and Laboratory Standards Institute (CLSI) methods, and partitioning was tested using the proportion method, after adjustment for unequal prevalences.

Results:

After outlier removal (men: 8.7%; women: 6.6%), 1414 men and 1082 women with estimated glomerular filtration rate (eGFR) ≥60 mL/min/1.73 m2 were assumed as non-AMI. Partitioning into age groups of 18–50, 51–70 and 71–98 years, the hs-cTnT 99th URLs adjusted on French prevalence were 18, 33, 66 and 16, 30, 84 ng/L for men and women, respectively. Age-partitioning was clearly required. However, sex-partitioning was not justified for subjects aged 18–50 and 51–70 years for whom a common hs-cTnT 99th URLs of about 17 and 31 ng/L could be used.

Conclusions:

Based on a laboratory approach, this study supports the need for age-specific hs-cTnT 99th URLs.


Corresponding author: Denis Monneret, PharmD, PhD, Department of Metabolic Biochemistry, La Pitié Salpêtrière-Charles Foix University Hospital (AP-HP), Assistance Publique-Hôpitaux de Paris (AP-HP), 47-83, boulevard de l’Hôpital, 75651 PARIS Cedex 13, France, Phone: (+33) 6 66 10 77 06

Acknowledgments

The authors thank Vincent Fitzpatrick for the English rereading.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551–67.10.1093/eurheartj/ehs184Search in Google Scholar PubMed

2. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254–61.10.1373/clinchem.2009.132654Search in Google Scholar PubMed

3. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574–81.10.1373/clinchem.2012.192716Search in Google Scholar PubMed

4. Menacer S, Claessens YE, Meune C, Elfassi Y, Wakim C, Gauthier L, et al. Reference range values of troponin measured by sensitive assays in elderly patients without any cardiac signs/symptoms. Clin Chim Acta 2013;417:45–7.10.1016/j.cca.2012.11.031Search in Google Scholar PubMed

5. Twerenbold R, Wildi K, Jaeger C, Gimenez MR, Reiter M, Reichlin T, et al. Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation 2015;131:2041–50.10.1161/CIRCULATIONAHA.114.014245Search in Google Scholar PubMed PubMed Central

6. Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012;33:2252–7.10.1093/eurheartj/ehs154Search in Google Scholar PubMed

7. Aakre KM, Sandberg S. Can changes in troponin results be useful in diagnosing myocardial infarction? Clin Chem 2010;56:1047–9.10.1373/clinchem.2010.146639Search in Google Scholar PubMed

8. Ricós C, Cava F, García-Lario JV, Hernández A, Iglesias N, Jiménez CV, et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004;64:175–84.10.1080/00365510410004885Search in Google Scholar PubMed

9. Dupuy AM, Lozano C, Badiou S, Bargnoux AS, Kuster N, Cristol JP. Biological variability of hs-cardiac troponin T on the Roche Cobas 8000/e602(®) immunoanalyzer. Clin Chim Acta 2013;425:62–3.10.1016/j.cca.2013.06.026Search in Google Scholar PubMed

10. Pretorius CJ, Wilgen U, Ungerer JP. Serial cardiac troponin differences measured on four contemporary analyzers: relative differences, actual differences and reference change values compared. Clin Chim Acta 2012;413:1786–91.10.1016/j.cca.2012.07.001Search in Google Scholar PubMed

11. Aakre KM, Røraas T, Petersen PH, Svarstad E, Sellevol H, Skadberg Ø, et al. Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clin Chem 2014;60:838–47.10.1373/clinchem.2013.216978Search in Google Scholar PubMed

12. Hassan HC, Howlin K, Jefferys A, Spicer ST, Aravindan AN, Suryanarayanan G, et al. High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population. Clin Chem 2014;60:389–98.10.1373/clinchem.2013.207142Search in Google Scholar PubMed

13. Mueller M, Biener M, Vafaie M, Doerr S, Keller T, Blankenberg S, et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012;58:209–18.10.1373/clinchem.2011.171827Search in Google Scholar PubMed

14. Kavsak PA, Hill SA, Bhanich Supapol W, Devereaux PJ, Worster A. Biomarkers for predicting serious cardiac outcomes at 72 hours in patients presenting early after chest pain onset with symptoms of acute coronary syndromes. Clin Chem 2012;58: 298–302.10.1373/clinchem.2011.172064Search in Google Scholar PubMed

15. Hammarsten O, Fu ML, Sigurjonsdottir R, Petzold M, Said L, Landin-Wilhelmsen K, et al. Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin Chem 2012;58:628–37.10.1373/clinchem.2011.171496Search in Google Scholar PubMed

16. Monneret D, Abbes RA, Omarjee R, Devilliers C, Le Manach Y, Raux M, et al. Analytical comparison of the new point-of-care troponin T immunoassay on AQT90Flex® analyzer (Radiometer) and the high-sensitivity troponin T immunoassay on ModularE170® (Roche Diagnostics). Clin Chem Lab Med 2014;52:e279–82.10.1515/cclm-2014-0231Search in Google Scholar PubMed

17. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter Suppl 2013;3:1–150.Search in Google Scholar

18. Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. J Am Med Assoc 2015;313:837–46.10.1001/jama.2015.0602Search in Google Scholar PubMed PubMed Central

19. Monneret D, Mestari F, Atlan G, Corlouer C, Ramani Z, Jaffre J, et al. Hemolysis indexes for biochemical tests and immunoassays on Roche analyzers: determination of allowable interference limits according to different calculation methods. Scand J Clin Lab Invest 2015;75:162–9.10.3109/00365513.2014.993691Search in Google Scholar PubMed

20. Tukey JW. Exploratory data analysis. Boston: Addison-Wesley, 1977.Search in Google Scholar

21. Clinical and Laboratory Standards Institute (23). Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline – third edition. Wayne (1): CLSI, 2008. Document C28-A3.Search in Google Scholar

22. Harris EK, Boyd JC. Statistical bases of reference values in laboratory medicine. New York: Marcel Dekker, Inc., 1995.10.1201/9781482273151Search in Google Scholar

23. Lahti A, Petersen PH, Boyd JC, Rustad P, Laake P, Solberg HE, et al. Partitioning of nongaussian-distributed biochemical reference data into subgroups. Clin Chem 2004;50:891–900.10.1373/clinchem.2003.027953Search in Google Scholar PubMed

24. Total population by sex and age in France. 2017. Institut National de la Statistique et des Etudes Economiques (INSEE). https://www.insee.fr/fr/statistiques/1892086&sommaire=1912926. Accessed January 2017.Search in Google Scholar

25. Saenger AK, Beyrau R, Braun S, Cooray R, Dolci A, Freidank H, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta 2011;412:748–54.10.1016/j.cca.2010.12.034Search in Google Scholar PubMed

26. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3–126.10.1089/105072503321086962Search in Google Scholar PubMed

27. Franzini M, Lorenzoni V, Masotti S, Prontera C, Chiappino D, Latta DD, et al. The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: a multicenter study in Italy. Clin Chim Acta 2015;438:376–81.10.1016/j.cca.2014.09.010Search in Google Scholar PubMed

28. Colantonio DA, Kyriakopoulou L, Chan MK, Daly CH, Brinc D, Venner AA, et al. Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 2012;58:854–68.10.1373/clinchem.2011.177741Search in Google Scholar PubMed

29. Henderson MP, Grey V. Establishing and evaluating pediatric thyroid reference intervals on the Roche Modular Analytics E 170 using computational statistics and data-mining techniques. Clin Biochem 2011;44:767–70.10.1016/j.clinbiochem.2011.05.006Search in Google Scholar PubMed

30. Hubert M, Van der Veeken S. Outlier detection for skewed data. J Chemometrics 2008;22:235–46.10.1002/cem.1123Search in Google Scholar

31. Horn PS, Feng L, Li Y, Pesce AJ. Effect of outliers and nonhealthy individuals on reference interval estimation. Clin Chem 2001;47:2137–45.10.1093/clinchem/47.12.2137Search in Google Scholar

32. Hickman PE, Koerbin G, Potter JM, Abhayaratna WP. Statistical considerations for determining high-sensitivity cardiac troponin reference intervals. Clin Biochem 2017;50:505–5.10.1016/j.clinbiochem.2017.02.022Search in Google Scholar PubMed

33. Eggers KM, Apple FS, Lind L, Lindahl B. The applied statistical approach highly influences the 99th percentile of cardiac troponin I. Clin Biochem 2016;49:1109–12.10.1016/j.clinbiochem.2016.08.012Search in Google Scholar PubMed

34. Harris EK, Boyd JC. On dividing reference data into subgroups to produce separate reference ranges. Clin Chem 1990;36:265–70.10.1093/clinchem/36.2.265Search in Google Scholar

35. Lahti A. Partitioning biochemical reference data into subgroups: comparison of existing methods. Clin Chem Lab Med 2004;42:725–33.10.1515/CCLM.2004.123Search in Google Scholar PubMed

36. Gellerstedt M. Partitioning reference values of several Gaussian subpopulations with unequal prevalence – a procedure with computer program support. Clin Chem Lab Med 2006;44:1258–63.10.1515/CCLM.2006.226Search in Google Scholar PubMed

37. Ungerer JP, Tate JR, Pretorius CJ. Discordance with 3 cardiac troponin I and T assays: implications for the 99th percentile cutoff. Clin Chem 2016;62:1106–14.10.1373/clinchem.2016.255281Search in Google Scholar PubMed

38. Apple FS, Jaffe AS, Collinson P, Mockel M, Ordonez-Llanos J, Lindahl B, et al. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem 2015;48:201–3.10.1016/j.clinbiochem.2014.08.021Search in Google Scholar PubMed

39. Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J. IFCC task force on clinical applications of cardiac bio-markers. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem 2017;63:73–81.10.1373/clinchem.2016.255109Search in Google Scholar PubMed

40. Rubini Giménez M, Twerenbold R, Boeddinghaus J, Nestelberger T, Puelacher C, Hillinger P, et al. Clinical effect of sex-specific cutoff values of high-sensitivity cardiac troponin t in suspected myocardial infarction. JAMA Cardiol 2016;1:912–20.10.1001/jamacardio.2016.2882Search in Google Scholar PubMed

41. Olivieri F, Galeazzi R, Giavarina D, Testa R, Abbatecola AM, Çeka A, et al. Aged-related increase of high sensitive Troponin T and its implication in acute myocardial infarction diagnosis of elderly patients. Mech Ageing Dev 2012;133:300–5.10.1016/j.mad.2012.03.005Search in Google Scholar PubMed

42. Mueller-Hennessen M, Lindahl B, Giannitsis E, Biener M, Vafaie M, deFilippi CR, et al. Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T – sub-analysis from the TRAPID-AMI study. Int J Cardiol 2016;209:26–33.10.1016/j.ijcard.2016.01.213Search in Google Scholar PubMed

43. Kuster N, Monnier K, Baptista G, Dupuy AM, Badiou S, Bargnoux AS, et al. Estimation of age- and comorbidities-adjusted percentiles of high-sensitivity cardiac troponin T levels in the elderly. Clin Chem Lab Med 2015;53:691–8.10.1515/cclm-2014-0121Search in Google Scholar PubMed

44. deFilippi C, Seliger SL, Kelley W, Duh SH, Hise M, Christenson RH, et al. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin Chem 2012;58:1342–51.10.1373/clinchem.2012.185322Search in Google Scholar PubMed

45. Chung JZ, Dallas Jones GR. Effect of renal function on serum cardiac troponin T – population and individual effects. Clin Biochem 2015;48:807–10.10.1016/j.clinbiochem.2015.05.004Search in Google Scholar PubMed

46. Parikh RH, Seliger SL, deFilippi CR. Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. Clin Biochem 2015;48:247–53.10.1016/j.clinbiochem.2015.01.004Search in Google Scholar PubMed

47. Wildi K, Gimenez MR, Twerenbold R, Reichlin T, Jaeger C, Heinzelmann A, et al. Misdiagnosis of myocardial infarction related to limitations of the current regulatory approach to define clinical decision values for cardiac troponin. Circulation 2015;131:2032–40.10.1161/CIRCULATIONAHA.114.014129Search in Google Scholar PubMed PubMed Central

48. Gore MO, Seliger SL, Defilippi CR, Nambi V, Christenson RH, Hashim IA, et al. Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol 2014;63:1441–8.10.1016/j.jacc.2013.12.032Search in Google Scholar PubMed PubMed Central

49. Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem 2012;58:219–25.10.1373/clinchem.2011.171082Search in Google Scholar PubMed

50. Ungerer JP, Marquart L, O‘Rourke PK, Wilgen U, Pretorius CJ. Concordance, variance, and outliers in 4 contemporary cardiac troponin assays: implications for harmonization. Clin Chem 2012;58:274–83.10.1373/clinchem.2011.175059Search in Google Scholar PubMed

51. Hickman PE, Lindahl B, Potter JM, Venge P, Koerbin G, Eggers KM. Is it time to do away with the 99th percentilefor cardiac troponin in the diagnosis of acute coronary syndrome and the assessment of cardiac risk? Clin Chem 2014;60:734–6.10.1373/clinchem.2013.217711Search in Google Scholar PubMed

52. Hickman PE, Koerbin G, Saenger AK, Kavsak PA. Statistical issues with the determination of the troponin 99th percentile – Not just a problem for troponin? Clin Biochem 2016;49:1105–6.10.1016/j.clinbiochem.2016.09.013Search in Google Scholar PubMed

53. Inal TC, Serteser M, Coşkun A, Ozpinar A, Unsal I. Indirect reference intervals estimated from hospitalized population for thyrotropin and free thyroxine. Croat Med J 2010;51:124–30.10.3325/cmj.2010.51.124Search in Google Scholar PubMed PubMed Central

54. Pottel H, Vrydags N, Mahieu B, Vandewynckele E, Croes K, Martens F. Establishing age/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta 2008;396:49–55.10.1016/j.cca.2008.06.017Search in Google Scholar PubMed

55. Willeit P, Welsh P, Evans JDW, Tschiderer L, Boachie C, Jukema JW, et al. High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154,052 participants. J Am Coll Cardiol 2017;70:558–68.10.1016/j.jacc.2017.05.062Search in Google Scholar PubMed PubMed Central

56. Solberg HE. Using a hospitalized population to establish reference intervals: pros and cons. Clin Chem 1994;40:2205–6.10.1093/clinchem/40.12.2205Search in Google Scholar

57. Concordet D, Geffré A, Braun JP, Trumel C. A new approach for the determination of reference intervals from hospital-based data. Clin Chim Acta 2009;405:43–8.10.1016/j.cca.2009.03.057Search in Google Scholar PubMed


Supplemental Material:

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2017-0256).


Received: 2017-3-24
Accepted: 2017-10-10
Published Online: 2017-11-25
Published in Print: 2018-4-25

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Scientific publishing in the “predatory” era
  4. The influence of age and other biological variables on the estimation of reference limits of cardiac troponin T
  5. Reviews
  6. Prognostic and predictive value of EGFR and EGFR-ligands in blood of breast cancer patients: a systematic review
  7. GSTP1 methylation in cancer: a liquid biopsy biomarker?
  8. Opinion Paper
  9. Practical recommendations for managing hemolyzed samples in clinical chemistry testing
  10. Genetics and Molecular Diagnostics
  11. Non-invasive prenatal diagnosis of paternally inherited disorders from maternal plasma: detection of NF1 and CFTR mutations using droplet digital PCR
  12. Circulating miR-21, miR-210 and miR-146a as potential biomarkers to differentiate acute tubular necrosis from hepatorenal syndrome in patients with liver cirrhosis: a pilot study
  13. Pleiotropy of ABO gene: correlation of rs644234 with E-selectin and lipid levels
  14. General Clinical Chemistry and Laboratory Medicine
  15. Three-year customer satisfaction survey in laboratory medicine in a Chinese university hospital
  16. Measurement of sirolimus concentrations in human blood using an automated electrochemiluminescence immunoassay (ECLIA): a multicenter evaluation
  17. Precision, accuracy, cross reactivity and comparability of serum indices measurement on Abbott Architect c8000, Beckman Coulter AU5800 and Roche Cobas 6000 c501 clinical chemistry analyzers
  18. Commutability of control materials for external quality assessment of serum apolipoprotein A-I measurement
  19. Development of a new biochip array for APOE4 classification from plasma samples using immunoassay-based methods
  20. Validation of a high-performance liquid chromatography method for thiopurine S-methyltransferase activity in whole blood using 6-mercaptopurine as substrate
  21. Increased serum concentrations of soluble ST2 are associated with pulmonary complications and mortality in polytraumatized patients
  22. Reference Values and Biological Variations
  23. Determination of age- and sex-specific 99th percentiles for high-sensitive troponin T from patients: an analytical imprecision- and partitioning-based approach
  24. Effect of preanalytical and analytical variables on the clinical utility of mean platelet volume
  25. Serum prolactin levels across pregnancy and the establishment of reference intervals
  26. Gender-partitioned patient medians of serum albumin requested by general practitioners for the assessment of analytical stability
  27. Cancer Diagnostics
  28. Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluid
  29. Cardiovascular Diseases
  30. No additional value of conventional and high-sensitivity cardiac troponin over clinical scoring systems in the differential diagnosis of type 1 vs. type 2 myocardial infarction
  31. Letters to the Editor
  32. Rare inclusion bodies within monocytes at accelerated phase of Chediak-Higashi syndrome
  33. A specific abnormal scattergram of peripheral blood leukocytes that may suggest hairy cell leukemia
  34. Spuriously low lymphocyte count associated with pseudoerythroblastemia in a patient with chronic lymphocytic leukemia treated with ibrutinib
  35. Performance evaluation of a new automated fourth-generation HIV Ag/Ab combination chemiluminescence immunoassay
  36. False increase of glycated hemoglobin due to aspirin interference in Tosoh G8 analyzer
  37. Assessment of in vitro stability: a call for harmonization across studies
  38. Comparison between blood gas analyzer and central laboratory analyzer for the determination of electrolytes in patients with acute respiratory acidosis
Downloaded on 22.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2017-0256/html?lang=en
Scroll to top button